[{"Assets_0_FY_USD":970111000.0,"CommonStockSharesOutstanding_0_FY_shares":40574060.0,"EarningsPerShareBasic_4_FY_USD":1.29,"EarningsPerShareBasic_1_FY_USD":0.93,"EarningsPerShareDiluted_4_FY_USD":1.13,"EarningsPerShareDiluted_1_FY_USD":0.77,"NetIncomeLoss_4_FY_USD":51776000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":49335112.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":40184159.0,"Ticker":"EBS","CIK":"1367644","name":"EMERGENT BIOSOLUTIONS INC.","OfficialName":"Emergent Biosolutions Inc. Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2077670312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20170228"}]